Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Open-Silicon is a fabless semiconductor company that specializes in custom Application-Specific Integrated Circuit (ASIC) and System-on-Chip (SoC) design and manufacturing. Founded in 2003, the company pioneered the "OpenMODEL" for ASIC development, providing end-to-end services from architecture and IP integration to silicon validation and manufacturing operations. While primarily a technology firm, Open-Silicon's custom solutions are utilized in high-growth sectors including healthcare, artificial intelligence, and networking, where they provide the underlying hardware for medical devices and diagnostic platforms. The company was acquired by SiFive in 2020 and subsequently sold to Alphawave Semi in 2022, where it continues to operate as part of the OpenFive business unit.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Open-Silicon.